ARWR - Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
ARWR - Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.